Loading…
Allowing Greater Access to Safe and Effective Contraception Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,805 other S bills in the 115th — cohort avg 41d
Allowing Greater Access to Safe and Effective Contraception Act This bill requires the Food and Drug Administration (FDA) to prioritize review of supplemental drug applications (applications to modify the approved use of a drug) for contraceptive drugs intended for routine use that would be available to individuals aged 18 and older without a prescription. The FDA must waive user fees for such supplemental drug applications. Any drug that is eligible for this priority review must be a prescription drug for individuals under age 18. This bill repeals provisions of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 to allow health savings accounts and health flexible spending accounts (HFSAs) to be used to pay for medicine without a prescription and to remove the limit on salary reduction contributions to a HFSA under a cafeteria plan, effective as if the provisions had never been enacted.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2018 · fourth_quarter · Pharmacy
Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Oral Contraceptives H.R. 421/S. 93 - Allowing Greater Access to Safe and Effective Contraception Act of 2017. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. S. 2825/H.R. 6378 -- Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018. To reauthorize certain programs under the Pandemic and All-Hazards Preparedness Reauthorization Act.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $197,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2018 · third_quarter · Health Issues
Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Health Disparities (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Lab Developed Tests (general); Contraception (general); Preeclampsia (general); Over the Counter Drugs (general); National Health Service Corps (general); Community Health Centers (general); Abortion (general); Hyde Amendment (General); Indian Health (general); Teaching Health Centers (general); Teen Pregnancy Prevention Program (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Health Care Reform (general); Title X (general); Personal Responsibility Education Program (general); Womens Preventive Services (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. 5977, MOMMAs Act; H.R.5761, Ending Maternal Mortality Act of 2018; S. 3392, MOMs Act; S. 3363, Maternal CARE Act; S.3494, MOMMIES Act; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; S.2852/H.R. 6378 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; S. 783, Improving Access to Maternity Care Act; S.Res. 605, A resolution designating the first week in August as World Breastfeeding Week, and designating August as National Breastfeeding Month; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; H.R. 6085/S. 3029, the PREEMIE Reauthorization Act; H.R. 3692, Addiction Treatment Access Improvement Act; S. 2680, Opioid Crisis Response Act; H.R. 5818/S. 2843, the Opioid Workforce Act of 2018; H.R. 2501/S. 1148, CRIB Act; H.R. 4993/ S.3253 - Vaccine Access Improvement Act of 2018; H.R. 6, SUPPORT for Patients and Communities Act; H.R. 6805, Pregnant Women in Custody Act; S. 2960 Access to Infertility Treatment and Care Act; H.J.Res. 140/S.J.Res. 63, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, Department of Labor, and the Department of Health and Human Services relating to Short-Term, Limited Duration Insurance; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act; H.R. 6545/S.___, Violence Against Women Reauthorization Act.
Client expense: $190,590 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
2018 · third_quarter · Pharmacy
Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Oral Contraceptives H.R. 421/S. 93 - Allowing Greater Access to Safe and Effective Contraception Act of 2017. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. S. 2825/H.R. 6378 -- Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018. To reauthorize certain programs under the Pandemic and All-Hazards Preparedness Reauthorization Act.
Client expense: $198,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2018 · second_quarter · Health Issues
Health Insurance Coverage (general); Genetic Screening and Testing (general); Health Disparities (general); Breastfeeding (general); Pregnancy Intention (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Health Disparities (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Lab Developed Tests (general); Stem Cell Research (general); Contraception (general); Preeclampsia (general); Drug Pricing (general); Over the Counter Drugs (general); National Health Service Corps (general); Community Health Centers (general); Abortion (general); Hyde Amendment (General); Indian Health (general);; Teaching Health Centers (general); ; Teen Pregnancy Prevention Program (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Zika Virus (general); Health Care Reform (general); Title X (general); Personal Responsibility Education Program (general); Womens Preventive Services (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. ___, MOMMAs Act; H.R.5761 - Ending Maternal Mortality Act of 2018; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; H.R. 1215/S.___ Protecting Access to Care Act; H.R. 1565, Saving Lives, Saving Costs Act; S.2852/H.R. 6378 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; H.R. 3120, To amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; S. 783, Improving Access to Maternity Care Act; ; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; ; H.R. 6085/S. 3029, the PREEMIE Reauthorization Act; H.R. 3692, Addiction Treatment Access Improvement Act; H.R. 5272, Reinforcing Evidence-Based Standards Under Law in Treating Substance Abuse Act; S. 2680, Opioid Crisis Response Act; H.R. 5562, Protecting NAS Babies Act; H.R. 2501/S. 1148, CRIB Act; H.R.___ Medicaid Partnership Act; H.R.___ To amend title XIX of the Social Security Act to provide for a demonstration project to increase substance use provider capacity under the Medicaid program; H.R. 3192, CHIP Mental Health Parity Act; H.R. ___, Incentivizing Non-Opioid Drugs; H.R. 6, SUPPORT for Patients and Communities Act; S. 3120, HEAL Act; S. 1113, Personal Care Products Safety Act; S. ___, Bipartisan Heath Care Stabilization Act; H.Res. 818/S.Res.459, Recognizing Black Maternal Health Week to bring national attention to the maternal health care crisis in the Black community and the importance of reducing the rate of maternal mortality and morbidity among Black Women; H. ___, Diagnostic Accuracy and Innovation Act (DAIA); S. 2960 Access to Infertility Treatment and Care Act; H.R.___/S.___ Violence Against Women Act; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act.
Client expense: $361,427 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
2018 · second_quarter · Pharmacy
Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Oral Contraceptives H.R. 421/S. 93 - Allowing Greater Access to Safe and Effective Contraception Act of 2017. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines.
Client expense: $255,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2018 · first_quarter · Health Issues
Health Insurance Coverage (general); Genetic Screening and Testing (general); Health Disparities (general); Emergency Contraception (general); Breastfeeding (general); Pregnancy Intention (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Domestic Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Health Disparities (general); Maternal Mortality and Morbidity (general); Imaging (general); Graduate Medical Education (general); Lab Developed Tests (general); Stem Cell Research (general); Contraception (general); Preeclampsia (general); National Health Service Corps (general); Community Health Centers (general); Abortion (general); Indian Health (general); Opioid Epidemic (general); Teaching Health Centers (general); H.R.3394/S. 1754, Teaching Health Centers Graduate Medical Education Extension Act of 2017/Training the Next Generation of Primary Care Doctors Act of 2017; Teen Pregnancy Prevention Program (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Zika Virus (general); Health Care Reform (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. ___, Kiras Law; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; H.R. 1215/S.___ Protecting Access to Care Act; H.R. 1565, Saving Lives, Saving Costs Act; H.R. 3120, To amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; H.R. 315/S. 783, Improving Access to Maternity Care Act; Hyde Amendment (General); H.R. 671/ S. 210, the Global Health Empowerment and Rights (Global HER) Act; HR 4418, the Enhancing Questions to Understand Intentions for Pregnancy (EQUIP) Act of 2017; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; H. Res. 205, expressing the sense of the House of Representatives with respect to ensuring that womens health care under current law is preserved; H.R. 2567/ S. 2259, Access to Birth Control (ABC) Act; H.R. 4082/S. 1985, Protect Access to Birth Control Act; S. 1045, Save Womens Preventive Care Act; H.R. 490, Heartbeat Protection Act; H.R. 36/S. 2311, Pain-Capable Unborn Child Protection Act; HR 4712, Born-Alive Abortion Survivors Protection Act; H.R. 3842, Healthy Start Reauthorization Act; H.R.__/S. ___, the PREEMIE Reauthorization Act; H.R. 3692, Addiction Treatment Access Improvement Act; H.R. 253/S. 1268, Family First Prevention Services Act/Child Protection and Family Support Act; H.R. 2545/S. 747, Special Diabetes Program for Indians Reauthorization Act; S. 1113, Personal Care Products Safety Act; Personal Responsibility Education Program (general); Womens Preventive Services (general); S. ___, Bipartisan Heath Care Stabilization Act; H.Res. 403/S.Res. 451, Supporting the designation of March 2018 as Endometriosis Awareness Month; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act.
2018 · first_quarter · Pharmacy
Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Oral Contraceptives H.R. 421/S. 93 - Allowing Greater Access to Safe and Effective Contraception Act of 2017. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines.
Client expense: $192,000 · Firm income: Not reported
2017 · fourth_quarter · Pharmacy
Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Oral Contraceptives H.R. 421/S. 93 - Allowing Greater Access to Safe and Effective Contraception Act of 2017. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines.
Client expense: $228,000 · Firm income: Not reported
2017 · fourth_quarter · Health Issues
Health Insurance Coverage (general); Genetic Screening and Testing (general); Health Disparities (general); Emergency Contraception (general); Breastfeeding (general); Pregnancy Intention (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Domestic Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Child Welfare (general); Prematurity (general); Health Disparities (general); Prevention and Public Health Fund (general); Maternal Mortality and Morbidity (general); Imaging (general); Graduate Medical Education (general); Lab Developed Tests (general); Stem Cell Research (general); Contraception (general); Preeclampsia (general); National Health Service Corps (general); Community Health Centers (general); Abortion (general); Indian Health (general); Teaching Health Centers (general); H.R.3394/S. 1754, Teaching Health Centers Graduate Medical Education Extension Act of 2017/Training the Next Generation of Primary Care Doctors Act of 2017; Teen Pregnancy Prevention Program (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Zika Virus (general); Health Care Reform (general); H.R.__/S. ___ Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; H.R. 1215/S.___ Protecting Access to Care Act; H.R. 1704, Accessible Care by Curbing Excessive Lawsuits (ACCESS) Act; H.R. 1565, Saving Lives, Saving Costs Act;; H.R. 3120, To amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; H.R. 315/S. 783, Improving Access to Maternity Care Act; S. Res. 319, a resolution supporting the goals, activities, and ideals of Prematurity Awareness Month; H.Res. 495/S.Res. 336, a resolution recognizing the seriousness of Polycystic Ovary Syndrome; Hyde Amendment (General);; H.R. 671/ S. 210, the Global Health Empowerment and Rights (Global HER) Act; HR 4418, the Enhancing Questions to Understand Intentions for Pregnancy (EQUIP) Act of 2017; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; H. Res. 205, expressing the sense of the House of Representatives with respect to ensuring that womens health care under current law is preserved; H.R. 2567/ S. 2259, Access to Birth Control (ABC) Act; H.R. 4082/S. 1985, Protect Access to Birth Control Act; H.R. 490, Heartbeat Protection Act; H.R. 36, Pain-Capable Unborn Child Protection Act; H.R. 3842, Healthy Start Reauthorization Act; H.R.__/S. ___, the PREEMIE Reauthorization Act; H.R. 3692, Addiction Treatment Access Improvement Act;; H.R. 253/S. 1268, Family First Prevention Services Act/Child Protection and Family Support Act; H.R. 2545/S. 747, Special Diabetes Program for Indians Reauthorization Act; Personal Responsibility Education Program (general); Womens Preventive Services (general); S. ___, Bipartisan Heath Care Stabilization Act; H.R. ____, CHAMPION Act; H.R. 4101, School Milk Nutrition Act; H.R. 2417/ S. 1101, Pregnant Workers Fairness Act; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act.
2017 · third_quarter · Health Issues
Health Insurance Coverage, Genetic Screening and Testing (general); Health Disparities (general); Emergency Contraception (general); Breastfeeding (general); Pregnancy Intention (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic devices (general); Reproductive Health (general); Domestic Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Child Welfare (general); Prematurity (general); Health Disparities (general); Prevention and Public Health Fund (general); Maternal Mortality and Morbidity (general); Electronic Health Records (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Lab Developed Tests (general); Stem Cell Research (general); Contraception (general); Postpartum Depression (general); Preeclampsia (general); National Health Service Corps (general); Community Health Centers (general); Abortion (general); Indian Health Care Improvement Act (general); Indian Health (general); Teaching Health Centers (general); H.R.3394/S. 1754, Teaching Health Centers Graduate Medical Education Extension Act of 2017/Training the Next Generation of Primary Care Doctors Act of 2017; Teen Pregnancy Prevention Program (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Zika Virus (general); Health Care Reform (general); Federal funding for Planned Parenthood (general); H.R.__/S. ___ Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; H.R. 1215 Protecting Access to Care Act; H.R. 1704, Accessible Care by Curbing Excessive Lawsuits (ACCESS) Act; H.R. 1565, Saving Lives, Saving Costs Act; HR 548/S 527, Health Care Safety Net Enhancement Act; HR 3120, To amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; H.R. 315/S. 783, Improving Access to Maternity Care Act; Hyde Amendment (General); H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; H.R3842, Healthy Start Reauthorization Act; H.R.__/S. ___, the PREEMIE Reauthorization Act; H.R. ___ legislation to protect the confidentiality of health care services; H.R. 3382, the Youth Opioid Use Treatment Help Act; H.R. 3692, Addiction Treatment Access Improvement Act; S. 1045, Save Womens Preventive Care Act; H.R. 253/S. 1268, Family First Prevention Services Act/Child Protection and Family Support Act; Gun violence (general); H.R. 2545/S. 747, Special Diabetes Program for Indians Reauthorization Act; Personal Responsibility Education Program (general); Womens Preventive Services (general); H.R. 1628, American Health Care Act/Better Care Reconciliation Act, Obamacare Repeal Reconciliation Act, Healthcare Freedom Act, Graham-Cassidy-Heller-Johnson Amendment ; H.R. 3635, Local Coverage Determination Clarification Act of 2017; H.R. 3922, CHAMPION Act; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act.
2017 · third_quarter · Pharmacy
Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Oral Contraceptives H.R. 421/S. 93 - Allowing Greater Access to Safe and Effective Contraception Act of 2017. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines.
Client expense: $176,000 · Firm income: Not reported
2017 · second_quarter · Pharmacy
Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Oral Contraceptives H.R. 421/S. 93 - Allowing Greater Access to Safe and Effective Contraception Act of 2017. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines.
Client expense: $215,000 · Firm income: Not reported
2017 · second_quarter · Health Issues
Health Insurance Coverage, Genetic Screening and Testing (general); Health Disparities (general); Emergency Contraception (general); Health Care Reform Implementation; Breastfeeding (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic devices (general); Reproductive Health (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Child Welfare (General); Prematurity (general); Health Disparities (general); Prevention and Public Health Fund (general); Maternal Mortality and Morbidity (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); Postpartum Depression (general); Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health Care Improvement Act (general); Indian Health (general); Teaching Health Centers (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Zika Virus (general); Health Care Reform (general); H.R. 1628, American Health Care Act; Federal funding for Planned Parenthood (general); H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; H.R. 1215 Protecting Access to Care Act; H.R. 1704, Accessible Care by Curbing Excessive Lawsuits (ACCESS) Act; H.R. 1565, Saving Lives, Saving Costs Act; HR 548/S 527, Health Care Safety Net Enhancement Act; H.R. 315/S. 783, Improving Access to Maternity Care Act; Hyde Amendment (General); H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; H.R.____, Healthy Start Reauthorization Act; S. 1045, Save Womens Preventive Care Act; H.R. 253/S. 1268, Family First Prevention Services Act/Child Protection and Family Support Act; H.R. 2501/S. 1148, CRIB Act; H.R. 2545/S. 747, Special Diabetes Program for Indians Reauthorization Act; S.___, Better Care Reconciliation Act; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act.
2017 · first_quarter · Health Issues
FDA OTC Monograph reform. S. 93: Allowing Greater Access to Safe and Effective Contraception Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2017 · first_quarter · Health Issues
Born Alive Abortion Survivors Protection Act (H.R. 37/S. 220) Allowing Greater Access to Safe and Effective Contraception Act (H.R. 421/S. 93) Women Veterans Access to Quality Care Act (S. 471) American Health Care Act (H.R. 1628) Providing for consideration of the bill (H.R. 1628) to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 (H. Res. 228) Providing for further consideration of the bill (H.R. 1628) to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2017 (H. Res. 254) Invest in Women's Health Act of 2017 (S. 689) Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule submitted by Secretary of Health and Human Services relating to compliance with title X requirements by project recipients in selecting subrecipients (H.J. Res. 43/S.J. Res. 13) Title X Abortion Provider Prohibition Act (H.R. 217) Defund Planned Parenthood Act of 2017 (H.R. 354) Protect Funding for Women's Health Care Act (S. 241) Nomination of Scott Gottlieb, of Connecticut, to be Commissioner of Food and Drugs, Department of Health and Human Services (P.N. 118) Nomination of Thomas Price, of Georgia, to be Secretary of Health and Human Services (P.N. 33)
Client expense: $444,877 · Firm income: Not reported
2017 · first_quarter · Health Issues
Health Insurance Coverage, Genetic Testing (general); Health Disparities (general); Maternal Mortality; Emergency Contraception (general); Health Care Reform Implementation; Breastfeeding (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic devices (general); Reproductive Health (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Child Welfare (General); Prematurity (general); Prevention and Public Health Fund (general); Maternal Mortality and Morbidity (general); Imaging (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); Postpartum Depression (general); CMS Provider Penalties (general); Preeclampsia (general); National Health Service Corps (general); Abortion (general); Indian Health Care Improvement Act (general); Indian Health (general); Teaching Health Centers (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Zika Virus (general); Health Care Reform (general); H.R. 1628, American Health Care Act; Federal funding for Planned Parenthood (general); H.R. 1318/S___, Preventing Maternal Deaths Act; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; H.R. 1215 Protecting Access to Care Act; H.R. 1565, Saving Lives, Saving Costs Act; HR 548/S 527, Health Care Safety Net Enhancement Act; H.R. 315/S. 783, Improving Access to Maternity Care Act; Hyde Amendment (General); HR 7/S 184, No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act; HR 421/S 93, Allowing Greater Access to Safe and Effective Contraception Act; HR 490, Heartbeat Protection Act; HJRes 43/SJRes 13, Title X Congressional Review Act; H.R.____, Healthy Start Reauthorization Act; HR____, Real Education for Healthy Youth Act; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act.
2017 · first_quarter · Pharmacy
Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Oral Contraceptives H.R. 421/S. 93 - Allowing Greater Access to Safe and Effective Contraception Act of 2017. Grants priority review of applications to switch oral contraceptive drugs from prescription to nonprescription (over-the-counter) status; all sections. Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines.
Client expense: $252,000 · Firm income: Not reported
Client expense: $553,520 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Client expense: $485,365 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Client expense: $451,075 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Client expense: $451,075 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $636,315 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of